Early and Intense Flu Season Revs Up
Drug Topics
DECEMBER 2, 2022
Flanked by RSV and COVID-19, flu season started early and rates of transmission are high throughout the country.
Fri.Dec 02, 2022
553 
Healthcare tech’s biggest busts
PharmaVoice
DECEMBER 2, 2022
The metaverse, blockchain, DCTs and more — here are some of the most recent fails in healthcare tech.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
News Roundup: November 28 to December 2
Drug Topics
DECEMBER 2, 2022
Your weekly roundup of the latest news from Drug Topics®.
STAT+: Alzheimer’s researchers try out an unfamiliar sensation: optimism
STAT
DECEMBER 2, 2022
SAN FRANCISCO — Scientific meetings about Alzheimer’s disease can be funereal affairs, with researchers from around the world gathering in hopes that the latest in a long line of negative clinical trials might light the path to a long-awaited success. This year was different. Nearly 2,000 people showed up to the Clinical Trials in Alzheimer’s Disease meeting, a conference record, to hear about lecanemab, a drug from Eisai and Biogen that appears to have broken the decades-lo
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacists Play Essential Role in Addressing Health Care Disparities
Pharmacy Times
DECEMBER 2, 2022
Diversity, equity, and inclusion programs in pharmacy can lead to better health outcomes for patients.
Industry Voices—The changing digital health landscape
Fierce Healthcare
DECEMBER 2, 2022
Industry Voices—The changing digital health landscape. hlandi. Fri, 12/02/2022 - 11:20.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Digital health VCs eye healthcare workforce, cancer care as ripe for startups in 2023
Fierce Healthcare
DECEMBER 2, 2022
Digital health VCs eye healthcare workforce, cancer care as ripe for startups in 2023. hlandi. Fri, 12/02/2022 - 06:26.
Tune in for Coverage of the 2022 San Antonio Breast Cancer Symposium
Pharmacy Times
DECEMBER 2, 2022
Pharmacy Times® will be onsite in Texas providing written and video content for the SABCS, which takes place December 6 to 10.
Opinion: Congress: Close the gap between funding for nutrition research and the toll diet-related disease takes on Americans
STAT
DECEMBER 2, 2022
You are what you eat. Every year, new scientific discoveries make clear that food is critical to health. In recent years, nutrition research trials have shown that a Mediterranean diet reduces cardiovascular disease; ultra-processed foods increase weight gain; omega-3 fatty acids improve IQ in preterm babies; cocoa prevents heart attacks; and vitamin D supplements do — well, almost nothing.
Oura launches employer-focused wellness arm
Fierce Healthcare
DECEMBER 2, 2022
Oura launches employer-focused wellness arm. aburky. Fri, 12/02/2022 - 11:49.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Opinion: Breakthrough Therapies Act: Good idea, wrong solution
STAT
DECEMBER 2, 2022
The Breakthrough Therapies Act , recently proposed by Senators Rand Paul (R-Ky.) and Cory Booker (D-N.J.) as a way to expand access for therapeutic purposes to potentially beneficial but highly regulated Schedule I substances like psilocybin and LSD, has the right underlying idea but provides a solution that is wrong. The act would automatically reclassify to Schedule II any experimental medicine designated by the Drug Enforcement Agency as a Schedule I controlled substance — defined as a
HHS bulletin clarifies when pixel tracker use may violate HIPAA
Fierce Healthcare
DECEMBER 2, 2022
HHS bulletin clarifies when pixel tracker use may violate HIPAA. pminemyer. Fri, 12/02/2022 - 15:21.
STAT+: AAM’s Dan Leonard, president of generic drug lobby, ousted
STAT
DECEMBER 2, 2022
The generic drug industry’s lobbying group, the Association for Accessible Medicines, fired its president Dan Leonard, two sources familiar with the decision said Friday evening. It was not immediately clear why Leonard was fired, and AAM didn’t immediately respond to a request for comment. The sources said its members were frustrated that it was late to engage when Congress was debating the Inflation Reduction Act, which gives Medicare the power to negotiate drug prices.
Olutasidenib Gains FDA Approval for IDH1-Mutated Relapsed/Refractory Acute Myeloid Leukemia
Pharmacy Times
DECEMBER 2, 2022
Olutasidenib (Rezlidhia) is indicated for adult patients with relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation detected by an FDA-approved test.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
In Philadelphia, ‘tranq’ is leaving drug users with horrific wounds. Other communities are bracing for the same
STAT
DECEMBER 2, 2022
PHILADELPHIA — The volunteers were handing out the staples of harm reduction: safe injection and smoking kits, condoms, and Narcan, the opioid overdose reversal medication. Down the line, they were distributing hats, socks, coats, and blankets to the people who use drugs who came to this outreach event on a recent Saturday, a bright, cold morning a few days before Thanksgiving.
Telemedicine Can Help Facilitate Treatment for Opioid Use Disorder
Pharmacy Times
DECEMBER 2, 2022
Program provides a virtual assessment and treatment with buprenorphine, a medication for opioid cravings and withdrawal symptoms.
CDC awards $3.2B to public health departments
Fierce Healthcare
DECEMBER 2, 2022
CDC awards $3.2B to public health departments. fdiamond. Fri, 12/02/2022 - 08:25.
FDA to Revise Labeling for Prescription Cough Medicine Following Overdose Concerns in Young Children
Pharmacy Times
DECEMBER 2, 2022
Benzonatate overdoses were reported in children under 2 years of age after accidentally ingesting as few as 1-2 capsules.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Image manipulation in science is suddenly in the news. But these cases are hardly rare
STAT
DECEMBER 2, 2022
In 2004, Mike Rossner and Kenneth Yamada, two top editors at the Journal of Cell Biology, wrote an editorial alerting readers to what they saw as an emerging problem in science: Thanks to Photoshop, researchers could prettify the images in their manuscripts in ways that might cross the line into deception in an effort to clear the bar of peer review.
CMS gives providers breathing room on looming advanced good faith cost estimates
Fierce Healthcare
DECEMBER 2, 2022
CMS gives providers breathing room on looming advanced good faith cost estimates. rking. Fri, 12/02/2022 - 14:29.
STAT+: An Anavex study spin job sullies an otherwise spectacular Alzheimer’s conference
STAT
DECEMBER 2, 2022
Anavex Life Sciences said Thursday that its experimental treatment for Alzheimer’s disease slowed the rate of cognitive decline in a clinical trial — but only by changing the study’s primary efficacy goals, omitting patients from the analysis, randomly altering data, making basic math errors, whistling past safety concerns, and using nonsensical statistical tests.
Advocate Aurora Health, Atrium Health close megamerger, forming the nation's 5th largest nonprofit system
Fierce Healthcare
DECEMBER 2, 2022
Advocate Aurora Health, Atrium Health close megamerger, forming the nation's 5th largest nonprofit system. pminemyer. Fri, 12/02/2022 - 16:26.
STAT+: Inside one startup’s quest to build proteins from scratch using artificial intelligence
STAT
DECEMBER 2, 2022
A Somerville startup and an academic lab in Seattle say they have developed a way to use artificial intelligence to design proteins that don’t exist in nature. Proteins help people move, digest food, and fight infections — to name a few of their numerous functions. They’re also the basis of a nearly $300 billion drug industry for treating cancer, immune diseases, and other conditions.
KFF: More large employers and unions turn to Medicare Advantage to offer retiree health benefits
Fierce Healthcare
DECEMBER 2, 2022
KFF: More large employers and unions turn to Medicare Advantage to offer retiree health benefits. rking. Fri, 12/02/2022 - 16:04.
STAT+: Up and down the ladder: The latest comings and goings
STAT
DECEMBER 2, 2022
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Do amoxicillin and alcohol mix?
The Checkup by Singlecare
DECEMBER 2, 2022
If you come down with a bacterial infection, you may be prescribed an antibiotic like amoxicillin. Treatment with amoxicillin typically lasts for several days, so you might be wondering whether combining amoxicillin and alcohol is safe, especially if the treatment course falls on a weekend or special occasion when you might be offered a cocktail or a glass of wine.
‘The hospital never supported the midwives’: As more birth centers open, their viability hinges on nearby hospitals
STAT
DECEMBER 2, 2022
BEVERLY, Mass. — It was fitting, one activist said, that the sky was storming on the night before the North Shore Birth Center closed, as patients, midwives, and community members gathered to commemorate its 42-year run. Over 30 people stood in a circle on the small hill by the cottage-like facility as rain whipped around them and the last of the daylight faded.
Improving trial predictability: leveraging AI-powered analytics to guide trial design, strategy, and operations
pharmaphorum
DECEMBER 2, 2022
Enrolling for clinical trials has become more challenging in recent years, with trial competition, increasingly complex protocols, and precision medicine targeting more niche patient populations. This emphasises sponsors’ need for enrolment predictability. The challenge the industry faces, however, is that operational certainty is exacerbated by the impact of global disruptions, such as the effect of COVID-19, natural disasters, and regional conflicts.
Vaccines Europe launches first pipeline review
European Pharmaceutical Review
DECEMBER 2, 2022
Vaccines Europe has unveiled its first pipeline review of its 15 members companies, with 100 vaccine candidates as of July 2022. . The review revealed a pipeline aimed at tackling current and future challenges, such as antimicrobial resistance (AMR) and respiratory tract infections, through leveraging a wide range of new technology platforms. The data indicated 46 percent of the vaccine candidates target infections that do not have an available vaccine.
Becerra decides to not extend mpox public health emergency set to expire next month
Fierce Healthcare
DECEMBER 2, 2022
Becerra decides to not extend mpox public health emergency set to expire next month. rking. Fri, 12/02/2022 - 16:39.
FDA approves Rezlidhia™ for leukaemia
European Pharmaceutical Review
DECEMBER 2, 2022
Rigel Pharmaceuticals, Inc. has announced the US Food and Drug Administration (FDA) has approved its oral drug Rezlidhia (olutasidenib) for adults with relapsed or refractory (R/R) acute myeloid leukaemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation. The FDA approval was supported by open-label Phase II registrational study data, which showed a twice per day 150mg dose of Rezlidhia facilitated a complete remission (CR) + CRh rate of 35 percent of the 153 patients observed.
STAT+: Pharmalittle: Private equity moving to buy clinical trials firms; data provider limits media access to drug prices
STAT
DECEMBER 2, 2022
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, for now, appears rather modest. We plan to promenade extensively with the official mascot, catch up on our reading, and have a listening party with Mrs. Pharmalot. And what about you?
Hashimoto’s Success Stories and Gratitude for Healing in 2022
The Thyroid Pharmacist
DECEMBER 2, 2022
Have you ever noticed that when we focus on our problems, it becomes too easy to find even more problems? No one is immune to the ups and downs of life – circumstances change, we experience loss, and the ongoing noise around us can become overwhelming. In the midst of all this, we might tend to allow our focus to rest on all that is outside of our control.
Let's personalize your content